Masimo Revenue 2010-2025 | MASI
Masimo annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Masimo revenue for the quarter ending June 30, 2025 was $0.371B, a 7.85% increase year-over-year.
- Masimo revenue for the twelve months ending June 30, 2025 was $2.154B, a 25.86% increase year-over-year.
- Masimo annual revenue for 2024 was $2.094B, a 2.26% increase from 2023.
- Masimo annual revenue for 2023 was $2.048B, a 0.6% increase from 2022.
- Masimo annual revenue for 2022 was $2.036B, a 64.28% increase from 2021.
| Masimo Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,094 |
| 2023 | $2,048 |
| 2022 | $2,036 |
| 2021 | $1,239 |
| 2020 | $1,144 |
| 2019 | $938 |
| 2018 | $858 |
| 2017 | $790 |
| 2016 | $713 |
| 2015 | $630 |
| 2014 | $587 |
| 2013 | $547 |
| 2012 | $493 |
| 2011 | $439 |
| 2010 | $405 |
| 2009 | $349 |
| Masimo Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-06-30 | $371 |
| 2025-03-31 | $372 |
| 2024-12-31 | $906 |
| 2024-09-30 | $505 |
| 2024-06-30 | $344 |
| 2024-03-31 | $340 |
| 2023-12-31 | $549 |
| 2023-09-30 | $479 |
| 2023-06-30 | $455 |
| 2023-03-31 | $565 |
| 2022-12-31 | $617 |
| 2022-09-30 | $549 |
| 2022-06-30 | $565 |
| 2022-03-31 | $304 |
| 2021-12-31 | $328 |
| 2021-09-30 | $307 |
| 2021-06-30 | $305 |
| 2021-03-31 | $299 |
| 2020-12-31 | $295 |
| 2020-09-30 | $278 |
| 2020-06-30 | $301 |
| 2020-03-31 | $270 |
| 2019-12-31 | $248 |
| 2019-09-30 | $229 |
| 2019-06-30 | $230 |
| 2019-03-31 | $232 |
| 2018-12-31 | $223 |
| 2018-09-30 | $211 |
| 2018-06-30 | $212 |
| 2018-03-31 | $213 |
| 2017-12-31 | $208 |
| 2017-09-30 | $193 |
| 2017-06-30 | $192 |
| 2017-03-31 | $197 |
| 2016-12-31 | $201 |
| 2016-09-30 | $168 |
| 2016-06-30 | $173 |
| 2016-03-31 | $171 |
| 2015-12-31 | $167 |
| 2015-09-30 | $153 |
| 2015-06-30 | $156 |
| 2015-03-31 | $155 |
| 2014-12-31 | $162 |
| 2014-09-30 | $144 |
| 2014-06-30 | $141 |
| 2014-03-31 | $140 |
| 2013-12-31 | $142 |
| 2013-09-30 | $131 |
| 2013-06-30 | $137 |
| 2013-03-31 | $136 |
| 2012-12-31 | $132 |
| 2012-09-30 | $119 |
| 2012-06-30 | $123 |
| 2012-03-31 | $119 |
| 2011-12-31 | $112 |
| 2011-09-30 | $104 |
| 2011-06-30 | $110 |
| 2011-03-31 | $113 |
| 2010-12-31 | $106 |
| 2010-09-30 | $101 |
| 2010-06-30 | $100 |
| 2010-03-31 | $99 |
| 2009-12-31 | $93 |
| 2009-09-30 | $87 |
| 2009-06-30 | $84 |
| 2009-03-31 | $85 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.590B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.057B | 22.51 |
| Intuitive Surgical (ISRG) | United States | $169.665B | 70.33 |
| IDEXX Laboratories (IDXX) | United States | $51.770B | 53.88 |
| Edwards Lifesciences (EW) | United States | $47.755B | 31.65 |
| Alcon (ALC) | Switzerland | $39.366B | 26.43 |
| IQVIA Holdings (IQV) | United States | $32.438B | 18.33 |
| DexCom (DXCM) | United States | $29.545B | 44.32 |
| Mettler-Toledo (MTD) | United States | $26.800B | 31.81 |
| STERIS (STE) | Ireland | $24.136B | 25.69 |
| Waters (WAT) | United States | $17.964B | 24.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
| Hologic (HOLX) | United States | $14.929B | 16.17 |
| Penumbra (PEN) | United States | $10.633B | 77.68 |
| Globus Medical (GMED) | United States | $8.275B | 19.09 |
| Sysmex ADR (SSMXY) | Japan | $7.913B | 25.14 |
| Teleflex (TFX) | United States | $5.586B | 9.02 |
| Glaukos (GKOS) | United States | $5.495B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.56 |
| Integer Holdings (ITGR) | United States | $3.779B | 18.86 |
| LivaNova (LIVN) | United Kingdom | $3.078B | 17.62 |
| Veracyte (VCYT) | United States | $2.387B | 32.98 |
| Alphatec Holdings (ATEC) | United States | $2.353B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.235B | 0.00 |
| Artivion (AORT) | United States | $2.073B | 104.60 |
| Nihon Kohden (NHNKY) | Japan | $1.992B | 23.78 |
| Elekta AB (EKTAY) | Sweden | $1.815B | 17.59 |
| Integra LifeSciences Holdings (IART) | United States | $1.179B | 6.75 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.046B | 0.00 |
| IRadimed (IRMD) | United States | $0.921B | 44.72 |
| Tandem Diabetes Care (TNDM) | United States | $0.845B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.819B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.719B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.554B | 9.79 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.439B | 3.52 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.385B | 91.83 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.48 |
| RxSight (RXST) | United States | $0.370B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.309B | 0.00 |
| NeuroPace (NPCE) | United States | $0.303B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 20.48 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.236B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| CVRx (CVRX) | United States | $0.205B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.107B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.60 |